Novel compound for treatment of allergy and asthma

Details for Australian Patent Application No. 2002251624 (hide)

International Classifications

Event Publications

3 April 2003 Application Open to Public Inspection

Published as AU-B-2002251624

21 December 2006 Change of Name(s) of Applicant(s), Section 104

Pharmacia Diagnostics AB The name of the applicant has been changed to Phadia AB

1 May 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Mar 2008

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

31 July 2008 Section 223 Application Allowed

Phadia AB The time in which to gain acceptance has been extended to 28 Aug 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

4 September 2008 Application Accepted

Published as AU-B-2002251624

2 October 2008 Corrigenda

Applications Accepted - Name Index Under the Name Phadia AB, Application No. 2002251624, under INID (72), correct the name of the co-inventor to Valenta, Rudolf

8 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.